Self-awareness has become an important research topic in Alzheimer's disease, with both decreased and increased awareness of cognitive deficits observed in the early stages of the disease. Understanding the pathological underpinning and factors associated with altered self-awareness is crucial for diagnostic purposes and its implications in patient treatment. The study by Furuya et al., showed that decreased awareness was associated with an increased likelihood of harboring amyloid pathology in cognitively normal and mild cognitive impairment participants. Here, we discuss these findings as well as psychiatric and social determinants of awareness and the need to refine tools to understand altered self-awareness.
SunderaramanPCosentinoS. Integrating the constructs of anosognosia and metacognition: a review of recent findings in dementia. Curr Neurol Neurosci Rep2017; 17: 17–27.
2.
PrigatanoGP. Historical observation relevant to the study of anosognosia. In: PrigatanoGP (ed.) The study of anosognosia. Oxford: Oxford University Press, 2010, pp.3–14.
3.
ReedBRJagustWJCoulterL. Anosognosia in Alzheimer’s disease: relationships to depression, cognitive function, and cerebral perfusion. J Clin Exp Neuropsychol1993; 15: 231–244.
4.
HanseeuwBJScottMRSikkesSAM, et al.Evolution of anosognosia in Alzheimer’s disease and its relationship to amyloid. Ann Neurol2020; 87: 267–280.
5.
VanniniPHanseeuwBJGatchelJR, et al.Trajectory of unawareness of memory decline in individuals with autosomal dominant Alzheimer disease. JAMA Netw Open2020; 3: e2027472.
6.
WilsonRSBoylePAYuL, et al.Temporal course and pathologic basis of unawareness of memory loss in dementia. Neurology2015; 85: 984–991.
7.
GerretsenPChungJKShahP, et al.Anosognosia is an independent predictor of conversion from mild cognitive impairment to Alzheimer’s disease and is associated with reduced brain metabolism. J Clin Psychiatry2017; 78: e1187–e1196.
8.
RobertsJLClareLWoodsRT. Subjective memory complaints and awareness of memory functioning in mild cognitive impairment: a systematic review. Dem Geriatr Cogn Disord2009; 28: 95–109.
9.
StarksteinSE. Anosognosia in Alzheimer's disease: diagnosis, frequency, mechanism and clinical correlates. Cortex2014; 61: 64–73.
10.
VanniniPAmariglioRHanseeuwB, et al.Memory self-awareness in the preclinical and prodromal stages of Alzheimer’s disease. Neuropsychologia2017; 99: 343–349.
11.
JessenFAmariglioREBuckleyRF, et al.The characterisation of subjective cognitive decline. Lancet Neurol2020; 19: 271–278.
12.
JonkerCGeerlingsMISchmandB. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry2000; 15: 983–991.
13.
CacciamaniFBercuABouteloupV, et al.Understanding factors associated with the trajectory of subjective cognitive complaints in groups with similar objective cognitive trajectories. Alzheimers Res Ther2023; 15: 205.
14.
CacciamaniFTandetnikCGagliardiG, et al.Low cognitive awareness, but not complaint, is a good marker of preclinical Alzheimer's disease. J Alzheimers Dis2017; 59: 753–762.
15.
López-MartosDSuárez-CalvetMMilà-AlomàM, et al.Awareness of episodic memory and meta-cognitive profiles: associations with cerebrospinal fluid biomarkers at the preclinical stage of the Alzheimer's continuum. Front Aging Neurosci2024; 16: 1394460.
16.
FuruyaYSatoKNiimiY, et al.Cognitive function instrument-based anosognosia to predict amyloid status. J Alzheimers Dis2025; 104: 995–1000.
17.
LiCNeugroschlJLuoX, et al.The utility of the Cognitive Function Instrument (CFI) to detect cognitive decline in non-demented older adults. J Alzheimers Dis2017; 60: 427–437.
18.
SperlingRADonohueMCRamanR, et al.Trial of solanezumab in preclinical Alzheimer's disease. N Engl J Med2023; 389: 1096–1107.
19.
NiimiYJanelidzeSSatoK, et al.Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly. Alzheimers Res Ther2024; 16: 115.
20.
BellaaliYWoodardJLHanseeuwB, et al.Spouse-appraised memory functioning predicts memory decline better than subjective memory complaints in community dwelling older adults at genetic risk for Alzheimer's disease. Front Psychiatry2021; 12: 633102.
21.
MograbiDCMorrisRG. On the relation among mood, apathy, and anosognosia in Alzheimer's disease. J Int Neuropsychol Soc2014; 20: 2–7.
22.
WangSMimmackKCacciamaniF, et al.Anosognosia is associated with increased prevalence and faster development of neuropsychiatric symptoms in mild cognitive impairment. Front Aging Neurosci2024; 16: 1335878.
23.
MigliorelliRTesónASabeL, et al.Anosognosia in Alzheimer's disease: a study of associated factors. J Neuropsychiatry Clin Neurosci1995; 7: 338–344.
24.
MartyrAClareLNelisSM, et al.Dissociation between implicit and explicit manifestations of awareness in early stage dementia: evidence from the emotional stroop effect for dementia-related words. Int J Geriatr Psychiatry2011; 26: 92–99.
25.
TondelliMBenuzziFBallottaD, et al.Eliciting implicit awareness in Alzheimer’s disease and mild cognitive impairment: a task-based functional MRI study. Front Aging Neurosci2022; 14: 816648.
26.
TondelliMBallottaDMaramottiR, et al.Resting-state networks and anosognosia in Alzheimer's disease. Front Aging Neurosci2024; 16: 1415994.
27.
TherriaultJNgKPPascoalTA, et al.Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology2018; 90: e932–e939.
